Healthtech Series C Investors & VC Firms
564 firms in this list, with a median first check of $1M. 141 of them lead rounds. Generated from verified public data and updated continuously.
Clal Biotechnology Industries
Tel AvivSeed–Late Stage
8 people
Healthcare Venture Partners, Llc
CharlestonSeries B–Late Stage
10 people
Korify Capital
Series A–Series C
6 people
Ming capital
ShenzhenSeed–Series C
6 people
Oltre Impact
MilanSeries A–Growth$2.2M – $8.6M
8 people
Vesalius Biocapital III Partners SàRL
ConternSeries B–Late Stage$10.8M
11 people
Oost NL
ApeldoornSeed–Late Stage$108K – $5.4M
2 people
Split Rock Partners
Eden PrairieSeed–Growth$2M – $40M
4 people
Novalis LifeSciences
PortsmouthSeed–Late Stage
9 people
Global BioAccess Fund
New YorkSeries A–Late Stage$10M
7 people
Iconica Partners
Silicon ValleySeed–Late Stage
4 people
Snatched Ventures
San FranciscoPre-Seed–Series C
2 people
Mitsui Sumitomo Insurance Capital
TokyoPre-Seed–Growth
3 people
Kern Capital, LLC
LarkspurSeries A–Late Stage$5M – $15M
1 person
Vocap Investment Partners
AtlantaPre-Seed–Late Stage
8 people
Alberta Innovates funding programs
CalgaryPre-Seed–Growth
10 people
Sequel Venture Partners
BoulderSeed–Series C
8 people
Whiz Partners Inc.
TokyoSeed–Late Stage$500K – $5M
6 people
IP Group
LondonSeed–Growth
2 people
NEOM
RiyadhPre-Seed–Series C
15 people
Mammoth Research
Fort WayneSeries A–Growth
9 people
ODYSSEE VENTURE
ParisSeries A–Late Stage$1.1M – $11M
3 people
Build Ventures
HalifaxSeed–Series C
3 people
GC1 Ventures
Series C
8 people
Related lists
Healthtech Investors & VC Firms (4227)Healthtech Seed Investors & VC Firms (3260)Healthtech Investors & VC Firms in North America (2705)Healthtech Investors & VC Firms in United States (2474)Healthtech Series A Investors & VC Firms (2328)Series C Investors & VC Firms (1709)Healthtech Pre-Seed Investors & VC Firms (1491)Healthtech Investors & VC Firms in Europe (1370)Healthtech Growth Investors & VC Firms (1282)Healthtech Investors & VC Firms in Global (1200)
Data sourced from public filings and firms' own websites — see our methodology.

































































